Herceptin
'Vast Majority' of Cancer Patients Lack Access to Essential Drugs Despite Advances, Says WHO Expert
Premium
Using Herceptin as an example, Andre Ilbawi detailed the challenges low- and medium-income countries face in accessing essential therapies.
The firm has ongoing trials evaluating evorpacept with monoclonal antibodies, checkpoint inhibitors, and antibody-drug conjugates.
Roche Reports 5 Percent CER Growth in Pharmaceutical Sales Driven by Strong Phesgo Uptake
In the first half of the year, sales of the injectable formulation of HER2-targeted agent grew 60 percent at CER, compared to H1 2023.
Merck Nets Confirmatory Data on Keytruda, Herceptin, Chemo Combo in HER2-Positive Gastric Cancer
The company will share with regulators worldwide data showing an overall survival advantage in this subset of advanced gastric cancer patients.
The study didn't meet its prespecified endpoint but suggests potential activity in HER2-amplified urothelial cancer and cholangiocarcinoma.